Shopping Cart
- Remove All
Your shopping cart is currently empty
TCN 201 is a selective antagonist of NMDA receptors containing the NR2A subunit.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $59 | In Stock | |
| 10 mg | $98 | In Stock | |
| 25 mg | $182 | In Stock | |
| 50 mg | $318 | In Stock | |
| 100 mg | $593 | In Stock |
| Description | TCN 201 is a selective antagonist of NMDA receptors containing the NR2A subunit. |
| In vitro | TCN-201, a new GluN1/GluN2A-selective NMDA receptor antagonist whose inhibition can be surmounted by glycine.?Electrophysiological recordings from chimeric and mutant rat NMDA receptors suggest that TCN-201 binds to a novel allosteric site located at the dimer interface between the GluN1 and GluN2 agonist binding domains.?Occupancy of this site by TCN-201 inhibits NMDA receptor function by reducing glycine potency.?TCN-201 is therefore a negative allosteric modulator of glycine binding[1]. |
| Synonyms | TCN-201 |
| Molecular Weight | 461.89 |
| Formula | C21H17ClFN3O4S |
| Cas No. | 852918-02-6 |
| Smiles | Fc1ccc(cc1Cl)S(=O)(=O)NCc1ccc(cc1)C(=O)NNC(=O)c1ccccc1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL (43.3 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.